As of 2025-09-18, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (11.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -256.3%.
The range of the Relative Valuation is (10.84) - (11.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.6x | 13.2x |
| Forward P/E multiples | 12.8x - 13.5x | 13.2x |
| Fair Price | (10.84) - (11.49) | (11.18) |
| Upside | -251.7% - -260.7% | -256.3% |
| Date | P/E |